Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study)
Br J Surg. 2024 Jun 12;111(6):znae145.
doi: 10.1093/bjs/znae145.
1 Department of Radiology, The First Hospital of China Medical University, Shenyang, China.
2 Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumours (China Medical University), Ministry of Education, Shenyang, China.